DiviDrip · INKT

INKT — MiNK Therapeutics, Inc.

INKT is MiNK Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $11.64. Market cap: $57M. Capital Quality Rank: 16/100 — Capital destroyer.

Stock snapshot

Price$11.64
Market cap$57M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)16 / 100 · Capital destroyer
Shareholder buyback yield-11.64%
Altman Z-score zoneDistress

About INKT

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Listed2021Employees15HQNew York, NYSectorHealthcareWebsiteminktherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside INKT. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is INKT's current stock price?

INKT (MiNK Therapeutics, Inc.) is currently trading at $11.64.

Does INKT pay a dividend?

INKT (MiNK Therapeutics, Inc.) does not currently pay a regular dividend.

What is INKT's Capital Quality Rank?

INKT has a Capital Quality Rank of 16/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track INKT in DiviDrip

Add INKT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow